ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3056

Efficacy of a Work Disability Prevention Program for People with Rheumatic and Musculoskeletal Conditions: A Randomized Controlled Trial

Julie J. Keysor1,2, Michael P. LaValley3, Carrie Brown4, David T. Felson5, Rawan AlHeresh6, Molly Vaughan7, Robert A. Yood8, John Reed9 and Saralynn Allaire10, 1Physical Therapy, Boston University, Boston, MA, 2Clinical Epidemiology Research and Training, Boston University School of Medicine, Boston, MA, 3Biostatistics, Boston University School of Public Health, Boston, MA, 4Boston University School of Public Health, Boston, MA, 5Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, 6Rheumatology, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia, 7635 Commonwealth Avenue, Room 651, Boston University College of Health & Rehabilitation Sciences, Boston, MA, 8Fallon Clinic, Worcester, MA, 9Rheumatology, Reliant Medical Group, Worcester, MA, 10Clinical Epidemiology Research and Training Unit, Clinical Epidemiology, BUSM, Boston, MA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Employment and Work Disability

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: ACR/ARHP Combined Abstract Session: Orthopedics and Rehabilitation

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Rheumatic and musculoskeletal conditions are leading causes of work disability. A previous trial showed a preventive work disability intervention delivered by vocational rehabilitation counselors (VRCs) reduced job loss among people with arthritis; however, VRC services are not readily available to most people with arthritis. Occupational therapists (OTs) and physical therapists (PTs) could implement a similar intervention, yet this has not been evaluated. The aim of this study was to examine the efficacy of a structured work disability prevention program delivered by OTs and PTs on work limitations and unemployment over two years.

Methods: This single-blind, parallel-arm randomized trial enrolled participants age 21-65 who were employed 15 or more hours/week, and reported a doctor-diagnosed rheumatic or musculoskeletal condition and a concern about staying employed due to their health. The intervention consisted of a 1.5 hour meeting, a written action plan, written materials on disability-related employment issues and supports, and telephone calls at 3-weeks and 3-months by trained OTs or PTs. Control group participants received the written materials but had no contact with the interventionists. The primary outcome was work limitations, measured with the Output Job Demand subscale of the Work Limitations Questionnaire (WLQ). The secondary outcome was unemployment: i) permanent and ii) both temporary and permanent. Intent to treat analyses were performed. For the primary analysis, a two-sample t-test was used to assess the effect of the intervention on the 24-month change in the WLQ subscale. As the secondary analysis, we evaluated the intervention effect on time to permanent unemployment using the Kaplan-Meier procedure and the log-rank test. The same approach was also used to evaluate the time to the first job loss (temporary or permanent). ClinicalTrials.gov NCT01387100.

Results: Between October 2011 and January 2014, 652 individuals were assessed for eligibility and 287 participants were randomized: 143 intervention and 144 control participants. 264 participants (92%) completed two year data collection. There was no difference in the mean WLQ change scores from baseline to two year follow-up (-8.6 ± 1.92 intervention vs. -8.33 ± 2.22 control (p=.93)); however, there was an effect on unemployment: 11 (8%) participants experienced permanent job loss at 2-years in the intervention arm and 25 (18%) in the control arm (p=.03) (Figure 1a). 47 (35%) intervention participants and 65 (46%) control participants experienced any unemployment during the follow up period (HR: 0.70 (0.48, 1.01), p = 0.06) (Figure 1b).

Conclusion: The intervention did not have an effect on work limitations but did reduce work cessation.

Figure 1: Cumulative Incidence of Time to Permanent (A) and Temporary or Permanent Unemployment (B)


Disclosure: J. J. Keysor, None; M. P. LaValley, None; C. Brown, None; D. T. Felson, None; R. AlHeresh, National Institute on Disability, Independent Living, and Rehabilitation Research, 2; M. Vaughan, None; R. A. Yood, None; J. Reed, None; S. Allaire, None.

To cite this abstract in AMA style:

Keysor JJ, LaValley MP, Brown C, Felson DT, AlHeresh R, Vaughan M, Yood RA, Reed J, Allaire S. Efficacy of a Work Disability Prevention Program for People with Rheumatic and Musculoskeletal Conditions: A Randomized Controlled Trial [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/efficacy-of-a-work-disability-prevention-program-for-people-with-rheumatic-and-musculoskeletal-conditions-a-randomized-controlled-trial/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/efficacy-of-a-work-disability-prevention-program-for-people-with-rheumatic-and-musculoskeletal-conditions-a-randomized-controlled-trial/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology